If you could vote on Brexit now which option would you choose?
   

Eli Lilly drug gets FDA nod for emergency use with remdesivir to treat COVID-19


The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co’s arthritis drug, baricitinib, in combination with Gilead Sciences Inc’s remdesivir, to treat COVID-19 patients. Baricitinib, sold under the brand name of Olumiant, is an FDA-approved oral medication to treat moderately-to-severely active rheumatoid arthritis. The approval was based on a review of the data from a clinical trial of hospitalized COVID-19 patients sponsored by the National Institute of Allergy and Infectious Diseases.

Reuters - November 19, 2020

View the full story here: https://www.reuters.com/article/us-health-coronavirus-eli-lilly-idUKKBN27Z35H